ARTICLES BY THIS AUTHOR
- 6/14/2022
Updated information about monkeypox and vaccination, as cases rise in Canada
A JAMA patient information sheet, NACI guidance on vaccinating high-risk people, and updated Canadian stats. - 6/8/2022
Type 2 diabetes may accelerate brain aging and cognitive decline
Investigators use data from a large cohort and a meta-analysis to characterize neurocognitive effects associated with type 2 diabetes. - 6/8/2022
POP QUIZ: Bacterial vaginosis: New vaginal antiseptic
Vablys (dequalinium chloride 10 mg vaginal tablets), a new vaginal antiseptic for bacterial vaginosis, is now available in Canada. Which statement about Vablys is FALSE? - 6/6/2022
Vaginal antiseptic for bacterial vaginosis Vablys now available in Canada
Dequalinium chloride, a quaternary ammonium antiseptic agent with anti-infective properties, acts locally within the vagina. - 6/1/2022
Do children with or without asthma have a similar risk of SARS-CoV2 infection?
New U.S. study has evaluated the association between asthma and SARS-CoV2 infection risk among children. - 5/30/2022
Risk of neurodevelopmental disorders after prenatal exposure to antiseizure meds
Prenatal exposure to topiramate, valproate and several dual therapies is associated with increased risk of autism spectrum disorder and/or intellectual disability. - 5/25/2022
What healthcare providers should look out for with suspected monkeypox cases appearing in Canada
In Ontario, any person meeting the case definition for monkeypox must be reported to Public Health Ontario within one business day. - 5/24/2022
POP QUIZ: New progestin-only oral contraceptive
Slynd, a new progestin-only oral contraceptive, is now available in Canada. Which statement about Slynd is FALSE? - 5/24/2022
Slynd: second oral progestin-only contraceptive now available in Canada
Backup nonhormonal contraception is not required unless two or more active tablet doses are missed. - 5/18/2022
Drug news—May
A review of new launches, new indications, new dosage forms and Health Canada advisories.